134 related articles for article (PubMed ID: 24405011)
1. The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.
Cadby G; Ward SV; Cole JM; Moses EK; Millward M; Palmer LJ
Br J Dermatol; 2014 Apr; 170(4):851-7. PubMed ID: 24405011
[TBL] [Abstract][Full Text] [Related]
2. The Western Australian Melanoma Health Study: study design and participant characteristics.
Ward SV; Cadby G; Lee A; Cole JM; Heyworth JS; Millward MJ; Wood FM; Palmer LJ
Cancer Epidemiol; 2011 Oct; 35(5):423-31. PubMed ID: 21474410
[TBL] [Abstract][Full Text] [Related]
3. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism.
Santonocito C; Capizzi R; Concolino P; Lavieri MM; Paradisi A; Gentileschi S; Torti E; Rutella S; Rocchetti S; Di Carlo A; Di Stasio E; Ameglio F; Zuppi C; Capoluongo E
Br J Dermatol; 2007 Feb; 156(2):277-82. PubMed ID: 17223867
[TBL] [Abstract][Full Text] [Related]
4. ICAM-1 polymorphisms and development of cutaneous malignant melanoma.
Howell WM; Rose-Zerilli MJ; Theaker JM; Bateman AC
Int J Immunogenet; 2005 Dec; 32(6):367-73. PubMed ID: 16313300
[TBL] [Abstract][Full Text] [Related]
5. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma.
McCarron SL; Bateman AC; Theaker JM; Howell WM
Int J Cancer; 2003 Nov; 107(4):673-5. PubMed ID: 14520709
[TBL] [Abstract][Full Text] [Related]
6. Association of TGFβ1 and clinical factors with scar outcome following melanoma excision.
Ward SV; Cadby G; Heyworth JS; Fear MW; Wallace HJ; Cole JM; Wood FM; Palmer LJ
Arch Dermatol Res; 2012 Jul; 304(5):343-51. PubMed ID: 22566144
[TBL] [Abstract][Full Text] [Related]
7. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of melanoma].
Maire C; Vercambre-Darras S; Desmedt E
Rev Prat; 2014 Jan; 64(1):61-8. PubMed ID: 24649548
[TBL] [Abstract][Full Text] [Related]
9. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
Okamoto I; Krögler J; Endler G; Kaufmann S; Mustafa S; Exner M; Mannhalter C; Wagner O; Pehamberger H
Int J Cancer; 2006 Sep; 119(6):1312-5. PubMed ID: 16596642
[TBL] [Abstract][Full Text] [Related]
10. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility.
Ibarrola-Villava M; Peña-Chilet M; Fernandez LP; Aviles JA; Mayor M; Martin-Gonzalez M; Gomez-Fernandez C; Casado B; Lazaro P; Lluch A; Benitez J; Lozoya R; Boldo E; Pizarro A; Martinez-Cadenas C; Ribas G
Eur J Cancer; 2011 Nov; 47(17):2618-25. PubMed ID: 21641795
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.
Hutchinson PE; Osborne JE; Lear JT; Smith AG; Bowers PW; Morris PN; Jones PW; York C; Strange RC; Fryer AA
Clin Cancer Res; 2000 Feb; 6(2):498-504. PubMed ID: 10690530
[TBL] [Abstract][Full Text] [Related]
13. Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism.
Ibarrola-Villava M; Martin-Gonzalez M; Lazaro P; Pizarro A; Lluch A; Ribas G
Br J Dermatol; 2012 Jun; 166(6):1176-83. PubMed ID: 22251241
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.
Orlow I; Reiner AS; Thomas NE; Roy P; Kanetsky PA; Luo L; Paine S; Armstrong BK; Kricker A; Marrett LD; Rosso S; Zanetti R; Gruber SB; Anton-Culver H; Gallagher RP; Dwyer T; Busam K; Begg CB; Berwick M;
Carcinogenesis; 2016 Jan; 37(1):30-8. PubMed ID: 26521212
[TBL] [Abstract][Full Text] [Related]
15. Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.
Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
Melanoma Res; 2009 Oct; 19(5):327-32. PubMed ID: 19593232
[TBL] [Abstract][Full Text] [Related]
16. Pigmentation-related genes and their implication in malignant melanoma susceptibility.
Fernandez LP; Milne RL; Pita G; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
Exp Dermatol; 2009 Jul; 18(7):634-42. PubMed ID: 19320733
[TBL] [Abstract][Full Text] [Related]
17. High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective.
Kasparian NA; Butow PN; Meiser B; Mann GJ
Psychooncology; 2008 Mar; 17(3):270-9. PubMed ID: 17600854
[TBL] [Abstract][Full Text] [Related]
18. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma.
Halsall JA; Osborne JE; Potter L; Pringle JH; Hutchinson PE
Br J Cancer; 2004 Aug; 91(4):765-70. PubMed ID: 15238985
[TBL] [Abstract][Full Text] [Related]
19. Inherited genetic variants associated with occurrence of multiple primary melanoma.
Gibbs DC; Orlow I; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):992-7. PubMed ID: 25837821
[TBL] [Abstract][Full Text] [Related]
20. Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study.
Veierød MB; Page CM; Aaserud S; Bassarova A; Jacobsen KD; Helsing P; Robsahm TE
J Am Acad Dermatol; 2018 Jul; 79(1):118-125.e1. PubMed ID: 29580861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
